TCMD
Tactile Systems Technology Inc
NASDAQ: TCMD · HEALTHCARE · MEDICAL DEVICES
$23.53
+0.91% today
Updated 2026-06-05
Market cap
$592.67M
P/E ratio
30.20
P/S ratio
1.73x
EPS (TTM)
$0.87
Dividend yield
—
52W range
$9 – $38
Volume
0.3M
Tactile Systems Technology Inc (TCMD) Insider transactions
Net insider activity
Net buying (855,515 shares)
Buy transactions
63
Sell transactions
37
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-11 | BIRKEMEYER, ELAINE M. | CHIEF FINANCIAL OFFICER | Sale | 4,631 | $24.49 | $113403.93 |
| 2026-05-06 | WASHINGTON, BOYD VINDELL | Director | Buy | 6,521 | — | — |
| 2026-05-06 | VOLKART, CARMEN B | Director | Buy | 6,521 | — | — |
| 2026-05-06 | SHAFER, DAVID BRENT | Director | Buy | 6,521 | — | — |
| 2026-05-06 | PEARSON, ANDREA | Director | Buy | 6,521 | — | — |
| 2026-05-06 | KING, LAURA G. | Director | Buy | 6,521 | — | — |
| 2026-05-06 | HUGGENBERGER, RAYMOND | Director | Buy | 6,521 | — | — |
| 2026-05-06 | BURKE, WILLIAM W | Director | Buy | 6,521 | — | — |
| 2026-05-06 | ASBURY, VALERIE L. | Director | Buy | 6,521 | — | — |
| 2026-03-09 | PEARSON, ANDREA | Director | Buy | 852 | — | — |
| 2026-02-24 | DODD, SHERI LOUISE | Director, Chief Executive Officer | Sale | 10,993 | $28.94 | $318144.02 |
| 2026-02-24 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Sale | 6,246 | $28.94 | $180764.24 |
| 2026-02-24 | BIRKEMEYER, ELAINE M. | CHIEF FINANCIAL OFFICER | Sale | 7,701 | $28.94 | $222880.03 |
| 2026-02-23 | DODD, SHERI LOUISE | Director, Chief Executive Officer | Sale | 14,703 | $28.28 | $415839.07 |
| 2026-02-23 | DODD, SHERI LOUISE | Director, Chief Executive Officer | Sale | 537 | $28.69 | $15406.05 |
| 2026-02-23 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Sale | 4,279 | $28.28 | $121021.67 |
| 2026-02-23 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Sale | 160 | $28.69 | $4590.29 |
| 2026-02-23 | BIRKEMEYER, ELAINE M. | CHIEF FINANCIAL OFFICER | Sale | 5,322 | $28.28 | $150520.53 |
| 2026-02-23 | BIRKEMEYER, ELAINE M. | CHIEF FINANCIAL OFFICER | Sale | 196 | $28.69 | $5623.08 |
| 2026-02-20 | DODD, SHERI LOUISE | Director, Chief Executive Officer | Buy | 28,216 | — | — |
| 2026-02-20 | DODD, SHERI LOUISE | Director, Chief Executive Officer | Buy | 19,751 | — | — |
| 2026-02-20 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Buy | 7,123 | — | — |
| 2026-02-20 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Buy | 4,058 | — | — |
| 2026-02-20 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Buy | 3,490 | — | — |
| 2026-02-20 | BIRKEMEYER, ELAINE M. | CHIEF FINANCIAL OFFICER | Buy | 15,575 | — | — |
| 2026-02-20 | BIRKEMEYER, ELAINE M. | CHIEF FINANCIAL OFFICER | Buy | 6,765 | — | — |
| 2026-02-20 | BIRKEMEYER, ELAINE M. | CHIEF FINANCIAL OFFICER | Buy | 3,579 | — | — |
| 2026-02-19 | DODD, SHERI LOUISE | Director, Chief Executive Officer | Buy | 48,672 | — | — |
| 2026-02-19 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Buy | 6,194 | — | — |
| 2026-02-19 | BIRKEMEYER, ELAINE M. | CHIEF FINANCIAL OFFICER | Buy | 23,008 | — | — |
| 2026-01-02 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Sale | 5,139 | $28.85 | $148260.15 |
| 2025-08-08 | DODD, SHERI LOUISE | Director, Chief Executive Officer | Sale | 7,762 | $12.36 | $95907.27 |
| 2025-05-12 | BIRKEMEYER, ELAINE M. | Chief Financial Officer | Sale | 2,921 | $9.94 | $29037.37 |
| 2025-05-08 | DODD, SHERI LOUISE | Director, Chief Executive Officer | Sale | 3,149 | $9.83 | $30954.67 |
| 2025-05-08 | BURKE, WILLIAM W | Director | Sale | 3,300 | $9.67 | $31911.00 |
| 2025-05-07 | WASHINGTON, BOYD VINDELL | Director | Buy | 16,078 | — | — |
| 2025-05-07 | VOLKART, CARMEN B | Director | Buy | 16,078 | — | — |
| 2025-05-07 | SHAFER, DAVID BRENT | Director | Buy | 16,078 | — | — |
| 2025-05-07 | KING, LAURA G. | Director | Buy | 16,078 | — | — |
| 2025-05-07 | HUGGENBERGER, RAYMOND | Director | Buy | 16,078 | — | — |
| 2025-05-07 | BURKE, WILLIAM W | Director | Buy | 16,078 | — | — |
| 2025-05-07 | ASBURY, VALERIE L. | Director | Buy | 16,078 | — | — |
| 2025-03-11 | REUVERS, DANIEL L. | Director | Buy | 68,162 | — | — |
| 2025-02-25 | REUVERS, DANIEL L. | Director | Sale | 28,338 | $14.18 | $401849.84 |
| 2025-02-25 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Sale | 6,468 | $14.40 | $93159.90 |
| 2025-02-25 | BIRKEMEYER, ELAINE M. | Chief Financial Officer | Sale | 2,066 | $14.51 | $29979.52 |
| 2025-02-24 | REUVERS, DANIEL L. | Director | Sale | 10,938 | $14.55 | $159146.81 |
| 2025-02-24 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Sale | 4,830 | $14.65 | $70752.74 |
| 2025-02-24 | BIRKEMEYER, ELAINE M. | Chief Financial Officer | Sale | 3,778 | $14.70 | $55538.11 |
| 2025-02-20 | REUVERS, DANIEL L. | Director | Buy | 15,853 | — | — |
| 2025-02-20 | KING, LAURA G. | Director | Buy | 2,970 | — | — |
| 2025-02-20 | DODD, SHERI LOUISE | Director, Chief Executive Officer | Buy | 65,669 | — | — |
| 2025-02-20 | DODD, SHERI LOUISE | Director, Chief Executive Officer | Buy | 20,108 | — | — |
| 2025-02-20 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Buy | 16,579 | — | — |
| 2025-02-20 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Buy | 4,131 | — | — |
| 2025-02-20 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Buy | 3,359 | — | — |
| 2025-02-20 | BIRKEMEYER, ELAINE M. | Chief Financial Officer | Buy | 36,248 | — | — |
| 2025-02-20 | BIRKEMEYER, ELAINE M. | Chief Financial Officer | Buy | 6,887 | — | — |
| 2025-02-20 | BIRKEMEYER, ELAINE M. | Chief Financial Officer | Buy | 3,446 | — | — |
| 2024-08-12 | FERSTLER, SHERRI LEE | Senior VP, Sales | Sale | 1,550 | $13.07 | $20262.53 |
| 2024-08-07 | DODD, SHERI LOUISE | Director, Chief Executive Officer | Buy | 64,959 | — | — |
| 2024-05-16 | BIRKEMEYER, ELAINE M. | Chief Financial Officer | Sale | 3,041 | $13.68 | $41589.63 |
| 2024-05-08 | WASHINGTON, BOYD VINDELL | Director | Buy | 10,469 | — | — |
| 2024-05-08 | VOLKART, CARMEN B | Director | Buy | 10,469 | — | — |
| 2024-05-08 | SHAFER, DAVID BRENT | Director | Buy | 10,469 | — | — |
| 2024-05-08 | HUGGENBERGER, RAYMOND | Director | Buy | 10,469 | — | — |
| 2024-05-08 | DODD, SHERI LOUISE | Director | Buy | 10,469 | — | — |
| 2024-05-08 | BURKE, WILLIAM W | Director | Buy | 10,469 | — | — |
| 2024-05-08 | BURKE, WILLIAM W | Director | Sale | 2,500 | $14.06 | $35150.00 |
| 2024-05-08 | ASBURY, VALERIE L. | Director | Buy | 10,469 | — | — |
| 2024-05-06 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Sale | 815 | $14.37 | $11712.77 |
| 2024-02-29 | REUVERS, DANIEL L. | Director, President and CEO | Sale | 1,396 | $15.25 | $21289.00 |
| 2024-02-29 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Sale | 243 | $15.25 | $3705.87 |
| 2024-02-27 | REUVERS, DANIEL L. | Director, President and CEO | Sale | 4,689 | $15.60 | $73148.40 |
| 2024-02-27 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Sale | 1,091 | $15.58 | $17001.16 |
| 2024-02-26 | REUVERS, DANIEL L. | Director, President and CEO | Sale | 6,239 | $15.81 | $98644.83 |
| 2024-02-26 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Sale | 2,015 | $15.91 | $32048.57 |
| 2024-02-24 | REUVERS, DANIEL L. | Director, President and CEO | Buy | 44,930 | — | — |
| 2024-02-24 | REUVERS, DANIEL L. | Director, President and CEO | Buy | 13,100 | — | — |
| 2024-02-24 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Buy | 8,986 | — | — |
| 2024-02-24 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Buy | 2,776 | — | — |
| 2024-02-24 | BIRKEMEYER, ELAINE M. | Chief Financial Officer | Buy | 2,848 | — | — |
| 2024-02-23 | REUVERS, DANIEL L. | Director, President and CEO | Sale | 5,378 | $14.85 | $79852.54 |
| 2024-02-23 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Sale | 2,249 | $14.80 | $33278.00 |
| 2024-02-21 | REUVERS, DANIEL L. | Director, President and CEO | Buy | 72,046 | — | — |
| 2024-02-21 | FERSTLER, SHERRI LEE | Senior VP, Sales | Buy | 21,613 | — | — |
| 2024-02-21 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Buy | 19,452 | — | — |
| 2024-02-21 | BIRKEMEYER, ELAINE M. | Chief Financial Officer | Buy | 32,420 | — | — |
| 2023-11-08 | WASHINGTON, BOYD VINDELL | Director | Buy | 8,700 | — | — |
| 2023-08-09 | FERSTLER, SHERRI LEE | Senior VP, Sales | Buy | 18,701 | — | — |
| 2023-08-07 | REUVERS, DANIEL L. | Director, President and CEO | Sale | 1,062 | $20.53 | $21807.64 |
| 2023-05-12 | BURKE, WILLIAM W | Director | Sale | 4,400 | $21.86 | $96184.00 |
| 2023-05-10 | BIRKEMEYER, ELAINE M. | Chief Financial Officer | Buy | 29,068 | — | — |
| 2023-05-08 | VOLKART, CARMEN B | Director | Buy | 7,737 | — | — |
| 2023-05-08 | SHAFER, DAVID BRENT | Director | Buy | 7,737 | — | — |
| 2023-05-08 | PAULS, ERIC | Senior VP, Sales | Sale | 550 | $18.55 | $10199.92 |
| 2023-05-08 | HUGGENBERGER, RAYMOND | Director | Buy | 7,737 | — | — |
| 2023-05-08 | DODD, SHERI LOUISE | Director | Buy | 7,737 | — | — |
| 2023-05-08 | BURNS, KRISTIE | Sr. VP Mktg & Clinical Affairs | Sale | 786 | $18.65 | $14658.98 |
| 2023-05-08 | BURKE, WILLIAM W | Director | Buy | 7,737 | — | — |
Frequently asked questions
Are TCMD insiders buying or selling?
Over the transactions on record, TCMD insiders have been net buyers, with about $3.31M in stock sold across 37 sales. The entries tagged as buys are stock grants and option exercises recorded at $0, not open-market purchases.
Does insider selling at TCMD mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which TCMD insiders are selling the most?
Recent selling is concentrated in a few names. DODD, SHERI LOUISE accounts for the largest share on record, with about $876251.07 sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.